The rise of Viagra initially drove a period of growth for major pharmaceutical companies, however recent changes present a uncertain outlook for investors. Off-patent competitors are reducing earnings, and persistent https://cecilyjsba370729.blogacep.com/46800558/sildenafil-and-pharma-a-risky-investment